Our featured speaker for this post is Mr Paul Casey, VP & Head, Asia Corporate Development, Quintiles, Singapore. He will be presenting at Pharma Partnering & Investment World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012.
A brief introduction to begin with: Mr Casey is responsible for Quintiles' corporate development and partnering functions for the Asia, Australia and Africa regions. These responsibilities include deal structuring, negotiation and due diligence. Mr Casey has been with Quintiles for 17 years. He has held leadership positions within Marketing and headed the CEO's office within Quintiles Informatics, overseeing the financial and administrative functions for that group. For the last eight years he has been heavily involved in Quintiles' partnering activities and has participated in numerous transactions over that period. Most recently Mr Casey was a leader in negotiating and finalizing Quintiles' joint venture with Samsung (announced February 2011) to support its entry into the global biopharmaceuticals market.
My Casey will be speaking on the following topics:
Leveraging on partnerships in accessing the markets of China
1. Examining the common challenges faced by global pharmas when accessing the markets of China
2. Licensing and partnership opportunities with Chinese companies and how to tap into this resource
3. Analyzing regulatory deterrents in China and learning what can be done to accelerate partnership deals